BrightOwl Loader Loading


Current Experience

  • Owner
    Since January 1997
    1) Together with Nick Geukens and Kevin Hollevoet from PharmAbs - Catholic University of Leuven - establishing an innovative disruptive biotech company. MIGHTY will express mAbs in vivo via an optimized minicircle DNA vector. Focus is on nosocomial diseases and oncology, proprietary targets and partnered mAbs 2) Building a vaccine company based on platform epitope identification programs 3) Support of Scandinavian and Baltic biotech companies 4) Collaboration with the province of Limburg to initiate long-term partnerships with Scandinavian, Baltic and US life sciences clusters 5) Creation of reconstructive CFM adipose stem cell/bioactive glass expertise center(s) and company together with BioMediTech (Tampere)

  • Owner
    Since November -0001

Past Experience

  • BD
    January 1994 --- January 1997

  • marketing
    January 1985 --- January 1994
    Vaccines portfolio management


LinkedIn Assessment :
VaccinesInfectious diseasesBiotechnologyTechnology transferLifesciencesmolecular biologyPharmaceutical IndustryoncologyImmunologyMedical DevicesLicensingCompetitive AnalysisBiopharmaceuticalsCommercializationIn VivoPharmaceutical salesAntibodiesSales EffectivenessDrug DevelopmentHardware DiagnosticsLife Sciences


  • Master's degree in Kinesiotherapy/Kinesiotherapist from Katholieke Universiteit Leuven in 1978
  • old humaniora in latin greek division from Heilig Hartcollege Maasmechelen in 1972

Area / Region

Maasmechelen, Belgium


Driving License
  • No